Puente-Barragán A, Velázquez-López L

Idioma: Inglés [English version]
Referencias bibliográficas: 14
Paginas: s22-24
Archivo PDF: 157.69 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA et al. he Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021; 397 (10292): 2385-2438. doi: 10.1016/S0140-6736(21)00684-X.

2. Ghazi L, Bello NA. Hypertension in women across the lifespan. Curr Atheroscler Rep. 2021; 23 (8): 43. doi: 10.1007/s11883-021-00941-4.

3. Ramirez LA, Sullivan JC. Sex differences in hypertension: where we have been and where we are going. Am J Hypertens. 2018; 31 (12): 1247-1254. doi: 10.1093/ajh/hpy148.

4. Sangaraju SL, Yepez D, Grandes XA, Talanki Manjunatha R, Habib S. Cardio-metabolic disease and polycystic ovarian syndrome (PCOS): a narrative review. Cureus. 2022; 14 (5): e25076. doi: 10.7759/cureus.25076.

5. Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020; 30 (7): 399-404. doi: 10.1016/j.tcm.2019.08.010.

6. Cameron NA, Blyler CA, Bello NA. Oral contraceptive pills and hypertension: a review of current evidence and recommendations. Hypertension. 2023; 80 (5): 924-935. doi: 10.1161/HYPERTENSIONAHA.122.20018.

7. Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020; 318 (6): F1315-F1326. doi: 10.1152/ajprenal.00071.2020.

8. Hallum S, Basit S, Kamper-Jorgensen M, Sehested TSG, Boyd HA. Risk and trajectory of premature ischaemic cardiovascular disease in women with a history of pre-eclampsia: a nationwide register-based study. Eur J Prev Cardiol. 2023: zwad003. doi: 10.1093/eurjpc/zwad003.

9. Nilsson PM, Viigimaa M, Giwercman A, Cifkova R. Hypertension and reproduction. Curr Hypertens Rep. 2020; 22 (4): 29. doi: 10.1007/s11906-020-01036-2.

10. Chih HJ, Elias FTS, Gaudet L, Velez MP. Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses. BMC Pregnancy Childbirth. 2021; 21 (1): 449. doi: 10.1186/s12884-021-03938-8.

11. Ghazi L, Annabathula RV, Bello NA, Zhou L, Stacey RB, Upadhya B. Hypertension across a woman's life cycle. Curr Hypertens Rep. 2022; 24 (12): 723-733. doi: 10.1007/s11906-022-01230-4.

12. Brahmbhatt Y, Gupta M, Hamrahian S. Hypertension in premenopausal and postmenopausal women. Curr Hypertens Rep. 2019; 21 (10): 74. doi: 10.1007/s11906-019-0979-y.

13. Anagnostis P, Theocharis P, Lallas K, Konstantis G, Mastrogiannis K, Bosdou JK et al. Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis. Maturitas. 2020; 135: 74-79. doi: 10.1016/j.maturitas.2020.03.006.

14. Madika AL, MacDonald CJ, Fournier A, Mounier-Vehier C, Béraud G, Boutron-Ruault MC. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort. Menopause. 2021; 28: 1204-1208.